MEBO INTERNATIONAL GROUP was founded in 1987. It is the only high tech industry group engaging in R&D of tissue organ in situ regenerative medicine. Twenty first century is the era of life science. MEBO INTERNATIONAL GROUP achieves unprecedented progress in exploring mysteries of life continuation and human health, and tries hard to explain secrets of life science. Completely different from the antagonistic thought of western medicine by tracing life origin and genetic materials to treat diseases, MEBO scientific researchers, Led by our pioneering, professor Rongxiang Xu, utilize the regenerative potentiality of adult tissue cell in situ to regenerate and repair the damaged tissue organs by way of activating, proliferating, and directionally differentiating potential regenerative cells (PRCs), meanwhile, provide physiologically moist environment and required nutrition to realize in situ regeneration and reparation of damaged tissue organs. This is a revolutionary achievement, and a significant milestone of life science. The first breakthrough is the skin tissue organ regenerative technique and product ---- MEBO Moist Exposed Burn Ointment. This technique can not only save the lives of the burn patients, but also achieve perfect efficacies-the patients healed without scar formation. This is firstly that human being can directly benefit from the clinical achievements of regenerative medicine. MEBO serial regenerative technologies and products can make significant contribution to human health, disease elimination and long life, and its achievements had received more than 10 patents in China, USA, Europe and Japan. MEBO INTERNATIONAL GROUP is located in Beijing, China and LA, USA. Now, it has many solely owned and joint stock companies for R&D, manufacturing and marketing. MEBO ointment have been officially registered and marketed in 23 countries till now.